Aptamer Group PLC (AIM:APTA)
London
· Delayed Price · Currency is GBP · Price in GBX 0.575
-0.025 (-4.17%)
Apr 28, 2026, 4:17 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 19.87 million as of April 28, 2026. Its market cap has increased by 283.72% in one year.
Market Cap
19.87M
Enterprise Value
18.67M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.58
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 19.87M, a decrease of -79.63%. That is a compound annual growth rate of -30.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 20.73M | -28.50% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 18.13M |
| Arecor Therapeutics | 24.92M |
| SkinBioTherapeutics | 25.27M |
| ImmuPharma | 28.08M |
| IXICO | 15.26M |
| Sareum Holdings | 28.30M |
| Genflow Biosciences | 14.19M |
| Poolbeg Pharma | 32.08M |